Methods and compositions for improved delivery via ultrasound
TW202633667APending Publication Date: 2026-08-16SONOTHERA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114144737
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-10-06
- Filing Date
- 2025-11-17
- Publication Date
- 2026-08-16
Smart Images

Figure TWG2TA001073023_001 
Figure TWG2TA001073023_002 
Figure TWG2TA001073023_003
Abstract
Provided are methods and compositions for expressing a functional dystrophin protein or a functional fragment thereof in a subject. The method can include administering a nucleic acid encoding the dystrophin protein to the subject, administering a sonoactive agent to the subject, and applying ultrasound energy the cell. Also provided are use of a nucleic acid encoding a functional dystrophin protein and a sonoactive agent in a method of treating a subject having a dystrophinopathy disorder requiring a dystrophin gene therapy or a dystrophin protein replacement therapy.
Need to check novelty before this filing date? Find Prior Art